{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:37:10Z","timestamp":1773189430078,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002724","name":"American University of Sharjah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002724","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dubai Falcon Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Posaconazole has been used anecdotally to treat aspergillosis in falcons resistant to voriconazole. In human medicine, it is used prophylactically in immunosuppressed human subjects with invasive pulmonary aspergillosis. So far, no studies have been performed in birds. The aim of this study was to evaluate the in-vivo pharmacokinetic behavior of oral posaconazole after a single administration in six large falcons (i.e gyrfalcons, saker falcons). Posaconazole oral suspension (Noxafil, 40 mg\/ml, Schering-Plough) was administered per os without meal in a single dosage of 12.5 mg\/kg in 3 falcons. A comparison was done in two more falcons, one with a natural fatty meal at the same single dose, and one with a natural fatty meal and a higher dosage (20 mg\/kg). Finally, six falcons received posaconazole pre-dissolved in corn oil with a natural low-fat meal in the higher single dose (20 mg\/kg). No side effects were observed in the falcons in any of the experiments. In starved state posaconazole was poorly absorbed, more so than in other species. As expected, absorption of posaconazole was higher with the administration of meal or in the presence of plant (corn) oil, with a fourfold increase in apparent bioavailability. Despite the preferential absorption in the presence of fat, for both dosing schemes the AUC24\u2009:\u2009MIC ratio was lower than described in human medicine to achieve a therapeutic effect. The AUCinf\u2009:\u2009MIC which is an indicator of efficacy after steady-state, while variable, did indicate that the drug is worth trying when susceptibility testing shows to be the only effective drug.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay Abstract<\/jats:title>\n                  <jats:p>The focus of this work is to determine the pharmacokinetic parameters of oral posaconazole in large falcons for the first time after a single dose. Posaconazole has higher bioavailability when administered with meal and fatty components. No adverse reactions have been observed. The ratio of the area under the curve (AUC24) to minimum inhibitory concentration was lower compared to the therapeutic level in human.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myab019","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T08:50:26Z","timestamp":1618822226000},"page":"901-908","source":"Crossref","is-referenced-by-count":4,"title":["Disposition of posaconazole after single oral administration in large falcons (<i>Falco spp<\/i>): Effect of meal and dosage and a non-compartmental model to predict effective dosage"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-9560","authenticated-orcid":false,"given":"Panagiotis","family":"Azmanis","sequence":"first","affiliation":[{"name":"Dubai Falcon Hospital, 23919, Dubai, United Arab Emirates (Azmanis, Silvanose)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Pappalardo","sequence":"additional","affiliation":[{"name":"Department of Biology, Chemistry and Environmental Studies, American University of Sharjah (AUS), United Arab Emirates (Pappalardo, Sara)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad A J","family":"Sara","sequence":"additional","affiliation":[{"name":"Department of Biology, Chemistry and Environmental Studies, American University of Sharjah (AUS), United Arab Emirates (Pappalardo, Sara)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christudas","family":"Silvanose","sequence":"additional","affiliation":[{"name":"Dubai Falcon Hospital, 23919, Dubai, United Arab Emirates (Azmanis, Silvanose)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinny","family":"Naidoo","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), Faculty of Veterinary Science, University of Pretoria, Republic of South Africa (Naidoo)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"2021090300022199400_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/mmy\/myv067","article-title":"Aspergillus and aspergilloses in wild and domestic animals: a global health concern with parallels to human disease","volume":"53","author":"Seyedmousavi","year":"2015","journal-title":"Med Mycol"},{"key":"2021090300022199400_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/vcp.12644","article-title":"The current status of avian aspergillosis diagnoses: veterinary practice to novel research avenues","volume":"47","author":"Savelieff","year":"2018","journal-title":"Vet Clin Pathol"},{"key":"2021090300022199400_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cvex.2018.01.009","article-title":"Antifungal therapy in birds: old drugs in a new jacket","volume":"21","author":"Antonissen","year":"2018","journal-title":"Vet Clin N Am Exot Anim Pract"},{"key":"2021090300022199400_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.jepm.2015.06.012","article-title":"Aspergillosis in birds: an overview of treatment options and regimens","volume":"24","author":"Krautwald-Junghanns","year":"2015","journal-title":"J Exot Pet Med"},{"key":"2021090300022199400_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.jepm.2015.06.016","article-title":"Diagnostic procedures and available techniques for the diagnosis of aspergillosis in birds","volume":"24","author":"Fischer","year":"2015","journal-title":"J Exot Pet Med"},{"key":"2021090300022199400_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/03079457.2010.506210","article-title":"Aspergillus infections in birds: a review","volume":"39","author":"Beernaert","year":"2010","journal-title":"Avian Pathol"},{"key":"2021090300022199400_bib7","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1080\/13693780400020089","article-title":"Aspergillosis in mammals and birds: impact on veterinary medicine","volume":"43","author":"Tell","year":"2005","journal-title":"Med Mycol"},{"key":"2021090300022199400_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/2213235X02666140905232309","article-title":"NMR-metabolomics study on falcons affected by aspergillosis","volume":"2","author":"Pappalardo","year":"2014","journal-title":"Curr Metabolomics"},{"key":"2021090300022199400_bib9","doi-asserted-by":"crossref","first-page":"e1006486","DOI":"10.1371\/journal.ppat.1006486","article-title":"Novel cutting-edge metabolite-based diagnostic tools for aspergillosis","volume":"13","author":"Savelieff","year":"2017","journal-title":"PLoS Pathog"},{"key":"2021090300022199400_bib10","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/AAC.01492-08","article-title":"Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole","volume":"53","author":"Beernaert","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090300022199400_bib11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3382\/ps.2013-03702","article-title":"Drug resistance of Aspergillus fumigatus strains isolated from flocks of domestic geese in Poland","volume":"93","author":"Zi\u00f3\u0142kowska","year":"2014","journal-title":"Poultry Sci"},{"key":"2021090300022199400_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/vr.159.9.282","article-title":"Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole","volume":"159","author":"Silvanose","year":"2006","journal-title":"Vet Rec"},{"key":"2021090300022199400_bib13","first-page":"95","article-title":"In vitro sensitivity of Aspergillus species isolated from respiratory tract of falcons","volume":"6","author":"Silvanose","year":"2011","journal-title":"Online Vet J"},{"key":"2021090300022199400_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/1471-2180-10-315","article-title":"Multiple-locus variable-number tandem repeat analysis for molecular typing of Aspergillus fumigatus","volume":"10","author":"Thierry","year":"2010","journal-title":"BMC Microbiol"},{"key":"2021090300022199400_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1637\/9088-092509-Reg.1","article-title":"Fungal pneumonia as a major cause of mortality in white stork (Ciconia ciconia) chicks","volume":"54","author":"Olias","year":"2010","journal-title":"Avian Dis"},{"key":"2021090300022199400_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/03079457.2010.540229","article-title":"Microsatellite typing of avian clinical and environmental isolates of Aspergillus fumigatus","volume":"40","author":"Van Waeyenberghe","year":"2011","journal-title":"Avian Pathol"},{"key":"2021090300022199400_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/13693786.2011.592860","article-title":"Molecular sub-typing suggests that the environment of rehabilitation centers may be a potential source of Aspergillus fumigatus infecting rehabilitating seabirds","volume":"50","author":"Burco","year":"2012","journal-title":"Med Mycol"},{"key":"2021090300022199400_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1099\/jmm.0.047803-0","article-title":"Microsatellite typing of Aspergillus flavus from clinical and environmental avian isolates","volume":"62","author":"Hadrich","year":"2013","journal-title":"J Med. Microbiol."},{"key":"2021090300022199400_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/S0100-736X2016000700005","article-title":"Identification and characterization of Aspergillus fumigatus isolates from broilers","volume":"36","author":"Spanamberg","year":"2016","journal-title":"Pesq Vet Brasil."},{"key":"2021090300022199400_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2021090300022199400_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2460\/ajvr.76.5.454","article-title":"Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs","volume":"76","author":"Kendall","year":"2015","journal-title":"Am J Vet Res"},{"key":"2021090300022199400_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/jvim.14523","article-title":"Posaconazole pharmacokinetics in healthy cats after oral and intravenous administration","volume":"30","author":"Mawby","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2021090300022199400_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jvp.12407","article-title":"Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration","volume":"40","author":"Gharibi","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"key":"2021090300022199400_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.45.3.857-869.2001","article-title":"Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia","volume":"45","author":"Petraitiene","year":"2001","journal-title":"Antimicrobl Agents Chemother"},{"key":"2021090300022199400_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.48.1.137-142.2004","article-title":"Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis","volume":"48","author":"Andes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090300022199400_bib26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jac\/dkm328","article-title":"Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats","volume":"60","author":"Ullmann A","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2021090300022199400_bib27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/infdis\/jir023","article-title":"Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy","volume":"203","author":"Howard","year":"2011","journal-title":"J Infect Dis"},{"key":"2021090300022199400_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090300022199400_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2016.10.010","article-title":"Blood and tissue distribution of posaconazole in a rat model of invasive pulmonary aspergillosis","volume":"87","author":"Cendejas-Bueno","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021090300022199400_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08998280.2007.11928283","article-title":"Posaconazole (Noxafil): a new triazole antifungal agent","volume":"20","author":"Greer","year":"2007","journal-title":"Baylor University Medical Center Proceedings"},{"key":"2021090300022199400_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.2010.03680.x","article-title":"Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview","volume":"70","author":"Lipp","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"2021090300022199400_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2125.2003.01977.x","article-title":"Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults","volume":"57","author":"Courtney","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"2021090300022199400_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2460\/ajvr.78.4.433","article-title":"Pharmacokinetics of a single dose of voriconazole administered orally with and without food to red-tailed hawks (Buteo jamaicensis)","volume":"78","author":"Parsley","year":"2017","journal-title":"Am J Vet Res"},{"key":"2021090300022199400_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0169-409X(96)00489-9","article-title":"Influence of lipolysis on drug absorption from the gastro-intestinal tract","volume":"25","author":"MacGregor","year":"1997","journal-title":"Adv Drug Deliv. Rev."},{"key":"2021090300022199400_bib35","doi-asserted-by":"crossref","first-page":"e152460","DOI":"10.11606\/issn.1678-4456.bjvras.2019.152460","article-title":"Aspergillosis in domestic and wild birds from Argentina","volume":"56","author":"Della Vedova","year":"2019","journal-title":"Braz J Vet Res Anim Sci"},{"key":"2021090300022199400_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/vr.161.8.265","article-title":"Plasma concentrations of voriconazole in falcons","volume":"161","author":"Schmidt","year":"2007","journal-title":"Vet Rec"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/9\/901\/39740667\/myab019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/9\/901\/39740667\/myab019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T21:14:01Z","timestamp":1630617241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/9\/901\/6248077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,4,23]]},"published-print":{"date-parts":[[2021,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myab019","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,4,23]]}}}